• Home
  • Meeting News
    • Pre-Meeeting: March 23
    • NEWS ARCHIVE
      • 2021
      • 2022
  • Attendee Map & Photos
  • Featured Industry Events
    • Satellite Educational Symposia
    • Exhibitor Spotlight Presentations
  • Featured Exhibitors
  • Meeting Home
Get News Updates
REGISTER NOW

  • Clinical vaccine research efforts target long-term goal of cancer prevention

    Clinical vaccine research efforts target long-term goal of cancer prevention

    May 5, 2022

    NCI Acting Director Douglas R. Lowy, MD, FAACR, chaired an Annual Meeting symposium that provided an update on clinical vaccine research efforts designed to prevent HPV, pancreatic cancer, and Lynch syndrome.

    READ MORE

  • Researchers are harnessing the microbiome to modulate treatment response

    Researchers are harnessing the microbiome to modulate treatment response

    May 5, 2022

    Beth McCormick, PhD, and two other investigators discussed the complex interplay between microorganisms and the tumor microenvironment and reviewed ongoing research using microbes to promote treatment response during an Annual Meeting symposium.

    READ MORE

  • Weinstein Foundation award lecturer describes groundbreaking PROTAC research

    Weinstein Foundation award lecturer describes groundbreaking PROTAC research

    May 5, 2022

    Craig M. Crews, PhD, was honored for his groundbreaking research that spearheaded new and revolutionary therapeutic approaches, including the development of novel proteasome inhibitors and proteolysis targeting chimera technology.

    READ MORE

  • Researchers discuss the potential of personalized cancer vaccines

    Researchers discuss the potential of personalized cancer vaccines

    May 5, 2022

    Neoantigens have emerged as prime targets for cancer immunotherapy in the past decade and researchers continue to explore approaches to improve antigen selection and immunogenicity for vaccine development. Ugur Sahin, MD, and Lélia Delamarre, PhD (left to right), discussed the latest advances at the Annual Meeting.

    READ MORE

  • Panel examines emerging clinical applications of liquid biopsy

    Panel examines emerging clinical applications of liquid biopsy

    May 5, 2022

    Klaus Pantel, MD, PhD, Catherine Alix-Panabières, PhD, and Victor E. Velculescu, MD, PhD (left to right), discussed the current state of the art, open questions, and potential clinical applications of liquid biopsy during the AACR Annual Meeting.

    READ MORE

  • Precancer early detection presents challenges but could hold benefits

    Precancer early detection presents challenges but could hold benefits

    May 5, 2022

    Philip E. Castle, PhD, MPH, Ernest T. Hawk, MD, MPH, and Nickolas Papadopoulos, PhD (left to right), discussed the challenges and benefits of detecting precancerous lesions in the era of minimally invasive tests like liquid biopsies on the final day of the Annual Meeting.

    READ MORE

  • Experts discuss how clonal hematopoiesis impacts cancer treatment decisions

    Experts discuss how clonal hematopoiesis impacts cancer treatment decisions

    May 5, 2022

    Growing evidence suggests a critical role for clonal hematopoiesis (CH) in driving complications associated with oncological care through systemic inflammation. Three investigators, including Ross L. Levine, MD, provided a state-of-the-art update on CH during one of the first-ever AACR Annual Meeting sessions dedicated to the topic.

    READ MORE


AACR Journals
myAACR
AACR Foundation
AACR Scientific Reports

AACR Blog: Cancer Research Catalyst
Cancer Today® Magazine
Leading Discoveries Magazine

© 2023 American Association for Cancer Research, All Rights Reserved.
Powered By TriStar Event Media, LLC. 

  • Privacy Policy
  • Twitter
  • Facebook
  • LinkedIn
  • YouTube

Get news updates from AACRMeetingNews.org

Subscribe below to get email updates from AACRMeetingNews.org